EduBourseActualitésAgilent Technologies Introduces High Sensitivity DNA Kit Targeting DNA, DNA Libraries in...

Agilent Technologies Introduces High Sensitivity DNA Kit Targeting DNA, DNA Libraries in Next Generation Sequencing Workflow

Agilent Technologies Inc. (NYSE:A) today introduced a new High Sensitivity DNA Kit for quality control, sizing and quantification of fragmented DNA and DNA libraries in the Next Generation Sequencing (NGS) workflow. The kit is used with the Agilent 2100 Bioanalyzer, the most successful microfluidics-based platform available commercially, offering solutions for the analysis of DNA, RNA, proteins and cells.

With its high sensitivity the kit will help NGS users working with double-stranded DNA to increase the fidelity of their sequencing data. It enables users to quantify DNA fragments in the lower single-digit pg/ìl concentration range. Many NGS sample-preparation protocols require DNA library amplification by PCR, which can often introduce amplification bias. The high sensitivity significantly lowers the number of required PCR cycles, reducing amplification artifacts and improving the quality of sequencing data.

“This is the most sensitive DNA detection method of all gel- and microfluidics-based systems currently on the market,” said Knut Wintergerst, electrophoresis marketing and support manager at Agilent. “The advent of NGS has dramatically changed the genetic landscape by significantly decreasing costs of a whole genome sequencing project while increasing experimental speed. Researchers need high quality DNA data quickly and Agilent has created a kit that provides just that.”

As the popularity of NGS platforms continues to rise and the premise of Pharmacogenomics continues to evolve, increasing the fidelity of NGS data is a crucial aspect of the workflow for researchers. With its ease of use, reliability, versatility – single stranded DNA QC and RNA QC in NGS workflows – and throughput of 12 samples in 30 minutes, the Agilent 2100 bioanalyzer is an ideal QC tool for NGS platforms.

Launched in 1999, the Agilent 2100 Bioanalyzer was the first commercially available instrument to use microfluidics technology for the analysis of biological samples. The 2100 Bioanalyzer can be used for electrophoresis and flow cytometry applications.

For more information please visit

About Agilent Technologies
Agilent Technologies Inc. (NYSE:A) is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company’s 19,000 employees serve customers in more than 110 countries. Agilent had net revenues of $5.8 billion in fiscal 2008. Information about Agilent is available on the Web at

# # #


Stuart Matlow
+1 408 553 7191
[email protected]

Pierre Perrin-Monlouis
Pierre Perrin-Monlouis
Fondateur de Rente et Patrimoine (cabinet de gestion de patrimoine), Pierre Perrin-Monlouis est un analyste et trader pour compte propre. Il vous fait profiter de son expérience en trading grâce à ses analyses financières et décrypte pour vous les actualités des marchés. Son approche globale des marchés combine à la fois l'analyse technique et l'analyse fondamentale sur l'ensemble des marchés : crypto, forex, actions et matières premières.